Literature DB >> 6110037

Attack rate of poststreptococcal nephritis in families. A prospective study.

B Rodríguez-Iturbe, L Rubio, R García.   

Abstract

Twenty-two families comprising 141 first-degree relatives (42 parents and 99 siblings) were studied prospectively after the appearance in the family of an index case with acute poststreptococcal glomerulonephritis (APSGN). There was no epidemic when the studies were conducted. Families were observed weekly for 4-6 weeks after the appearance of the index case, and at least every 6 months thereafter for 1-3 years. At each examination all members of the family gave a history and had a physical examination, urine analysis, and appropriate cultures; antistreptococcal antibody titres and serum C3 were determined. 33 parents and 95 siblings showed changes in antistreptococcal antibody titres suggestive of infection during or shortly before the period of weekly observation. Group A streptococci of various M and T types were isolated from 17 individuals in 14 families. 25 cases of clincal APSGN (including 22 index cases) and 12 cases of asymptomatic APSGN were detected. The results indicate that within families the streptococci responsible for nonepidemic APSGN are very infectious. The subclinical/clinical disease ratio (excluding index cases) was 4.0. The high attack rate (37.8%) in 77 sibling contacts at risk may indictae that susceptibility to nephritis after streptococcal infection is a familial trait.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6110037     DOI: 10.1016/s0140-6736(81)91788-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

1.  Post-streptococcal acute glomerulonephritis in Chile--20 years of experience.

Authors:  Ximena Berríos; Edda Lagomarsino; Eric Solar; Gloria Sandoval; Beatriz Guzmán; Ingrid Riedel
Journal:  Pediatr Nephrol       Date:  2003-12-20       Impact factor: 3.714

Review 2.  Post-streptococcal acute glomerulonephritis in children: clinical features and pathogenesis.

Authors:  T Matthew Eison; Bettina H Ault; Deborah P Jones; Russell W Chesney; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2010-07-23       Impact factor: 3.714

3.  American Society of Nephrology Quiz and Questionnaire 2012: glomerulonephritis.

Authors:  Fernando C Fervenza; Richard J Glassock; Anthony J Bleyer
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

4.  Clinical profile of acute glomerulonephritis in children.

Authors:  M Singh; E Azizi; M A Qureshi; L S Arya
Journal:  Indian J Pediatr       Date:  1984 Sep-Oct       Impact factor: 1.967

5.  Mendelian recessive ratios in acute poststreptococcal glomerulonephritis.

Authors:  B Rodríguez-Iturbe; H Moreno-Fuenmayor; L Rubio; R García; Z Layrisse
Journal:  Experientia       Date:  1982-08-15

6.  Systematic Review of Group A Streptococcal emm Types Associated with Acute Post-Streptococcal Glomerulonephritis.

Authors:  Kate A Worthing; Jake A Lacey; David J Price; Liam McIntyre; Andrew C Steer; Steven Y C Tong; Mark R Davies
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

Review 7.  An update on acute postinfectious glomerulonephritis worldwide.

Authors:  Talerngsak Kanjanabuch; Wipawee Kittikowit; Somchai Eiam-Ong
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

8.  Streptococcal pharyngitis in general practice. 2. A note on dual infection and transient urinary abnormalities.

Authors:  P M Higgins
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

Review 9.  Autoimmunity in Acute Poststreptococcal GN: A Neglected Aspect of the Disease.

Authors:  Bernardo Rodriguez-Iturbe
Journal:  J Am Soc Nephrol       Date:  2021-02-02       Impact factor: 10.121

10.  The Epidemiology, Clinical Features, and Outcome of Infection-related Glomerulonephritis from East India: A Single Center Experience.

Authors:  M Trivedi; A Pasari; A R Chowdhury; A A Kurien; R Pandey
Journal:  Indian J Nephrol       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.